The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD371 (Clec12A) expression on mouse spleen dendritic cell subsets. Mouse splenocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with FITC Hamster Anti-Mouse CD3e (Cat. No. 553062/553061/561827), PerCP-Cy™5.5 Hamster Anti-Mouse CD11c (Cat. No. 560584), APC-H7 Rat Anti-Mouse CD19 (Cat. No. 560143/560245), PE Rat Anti-Mouse CD45R/B220 (Cat. No. 553089/553090/561878), and BD Horizon™ PE-CF594 Rat Anti-Mouse CD49b (Cat. No. 562453) antibodies and either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562602; dashed line histograms) or BD Horizon BV421 Rat Anti-Mouse CD371 (Clec12A) antibody (Cat. No. 564795; solid line histograms).
Overlapping histograms showing CD371 expression (or Ig Isotype control staining) on either CD11c-high CD45R/B220- (Left Panel) or CD11c-intermediate CD45R/B220+ (Right Panel) cells were derived from gated events with the forward and side light-scatter characteristics of viable CD3- CD19- CD49b- leucocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For optimal and reproducible results, BD Horizon Brilliant™ Stain Buffer should be used anytime BD Horizon Brilliant™ dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The 5D3/CD371 (aka, 1/06-5D3) monoclonal antibody specifically binds to mouse CD371 which is encoded by Clec12A (C-type lectin domain family 12 member A). CD371 is also known as Myeloid inhibitory C-type lectin-like receptor (MICL), C-type lectin-like molecule 1 (CLL-1) or Dendritic cell-associated lectin 2 (DCAL-2). CD371 is a ~30 kDa type II transmembrane glycoprotein that possesses one extracellular C-type lectin domain and one cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM). CD371 is expressed on plasmacytoid dendritic cells, subsets of myeloid dendritic cells, monocytes, macrophages and B cells. It reportedly serves as a negative regulator of granulocyte and monocyte function.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.